The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malaviya, R.
Right arrow Articles by Uckun, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malaviya, R.
Right arrow Articles by Uckun, F. M.
The Journal of Immunology, 2002, 168: 421-426.
Copyright © 2002 by The American Association of Immunologists

Role of STAT6 in IgE Receptor/Fc{varepsilon}RI-Mediated Late Phase Allergic Responses of Mast Cells

Ravi Malaviya* and Fatih M. Uckun1,{dagger}

Departments of * Allergy and {dagger} Immunology, Parker Hughes Institute, St. Paul, MN 55113

In this study we show that IgE receptor engagement triggers activation of STAT6 in mast cells. We sought to determine the role of STAT6 activation in IgE receptor-mediated mast cell responses using STAT6 knockout mice. After IgE receptor engagement, bone marrow mast cells from STAT6-/- mice exhibited normal histamine and leukotriene C4 release, but their cytokine release was markedly reduced. In accordance with these in vitro data, IgE/Ag-challenged STAT6-/- mice showed normal early phase, but severely impaired late phase, allergic reactions. These findings provide unprecedented evidence that STAT6 plays a pivotal role in mast cell responses to IgE/Ag st imulation.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
B. O. Barnstein, G. Li, Z. Wang, S. Kennedy, C. Chalfant, H. Nakajima, K. D. Bunting, and J. J. Ryan
Stat5 Expression Is Required for IgE-Mediated Mast Cell Function.
J. Immunol., September 1, 2006; 177(5): 3421 - 3426.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Artis, A. Villarino, M. Silverman, W. He, E. M. Thornton, S. Mu, S. Summer, T. M. Covey, E. Huang, H. Yoshida, et al.
The IL-27 Receptor (WSX-1) Is an Inhibitor of Innate and Adaptive Elements of Type 2 Immunity
J. Immunol., November 1, 2004; 173(9): 5626 - 5634.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. R. Hundley, A. M. Gilfillan, C. Tkaczyk, M. V. Andrade, D. D. Metcalfe, and M. A. Beaven
Kit and Fc{epsilon}RI mediate unique and convergent signals for release of inflammatory mediators from human mast cells
Blood, October 15, 2004; 104(8): 2410 - 2417.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. B. Madden, L. Whitman, C. Sullivan, W. C. Gause, J. F. Urban Jr., I. M. Katona, F. D. Finkelman, and T. Shea-Donohue
Role of STAT6 and Mast Cells in IL-4- and IL-13-Induced Alterations in Murine Intestinal Epithelial Cell Function
J. Immunol., October 15, 2002; 169(8): 4417 - 4422.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.